D. Gouet

Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

Adrian F. Hernandez, Jennifer B. Green, Salim Janmohamed et al. · The Lancet · 2018 · 1.7K citations · Full text

Diabetes Management, Cardiovascular Disease, Diabetes +6

Efficacy and Safety of IDegLira Versus Basal-Bolus Insulin Therapy in Patients With Type 2 Diabetes Uncontrolled on Metformin and Basal Insulin: The DUAL VII Randomized Clinical Trial

Liana K. Billings, Ankur Doshi, D. Gouet et al. · Diabetes Care · 2018 · 179 citations · Full text

Frequency and predictors of confirmed hypoglycaemia in type 1 and insulin-treated type 2 diabetes mellitus patients in a real-life setting: Results from the DIALOG study

Bertrand Cariou, P. Fontaine, É. Eschwège et al. · Diabetes & Metabolism · 2014 · 130 citations

Metabolic Syndrome, Type 1, Diabetes Management +11

A New-Generation Ultra-Long-Acting Basal Insulin With a Bolus Boost Compared With Insulin Glargine in Insulin-Naïve People With Type 2 Diabetes

Tim Heise, Cees J. Tack, Robert Cuddihy et al. · Diabetes Care · 2011 · 96 citations · Full text

Metformin use is associated with a reduced risk of mortality in patients with diabetes hospitalised for COVID-19

Jean‐Daniel Lalau, Abdallah Al‐Salameh, Samy Hadjadj et al. · Diabetes & Metabolism · 2020 · 93 citations · Full text

Metabolic Syndrome, Reduced Risk, Diabetes Management +11